AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
22.27
+1.10 (5.20%)
Nov 22, 2024, 4:00 PM EST - Market closed
AnaptysBio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 191.58 | 35.97 | 71.31 | 495.73 | 250.46 | 171.02 | Upgrade
|
Short-Term Investments | 238.54 | 354.94 | 369.93 | 52.37 | 143.2 | 203.21 | Upgrade
|
Cash & Short-Term Investments | 430.12 | 390.9 | 441.24 | 548.1 | 393.65 | 374.23 | Upgrade
|
Cash Growth | 4.13% | -11.41% | -19.50% | 39.23% | 5.19% | -12.38% | Upgrade
|
Accounts Receivable | 12.2 | 6.85 | 1.42 | 0.88 | - | - | Upgrade
|
Receivables | 12.2 | 6.85 | 1.42 | 0.88 | - | - | Upgrade
|
Prepaid Expenses | 6.37 | 9.08 | 4.55 | 4.9 | 2.91 | 3.51 | Upgrade
|
Total Current Assets | 448.68 | 406.84 | 447.21 | 553.88 | 396.56 | 377.73 | Upgrade
|
Property, Plant & Equipment | 16.57 | 18.27 | 19.99 | 21.84 | 2.13 | 3.02 | Upgrade
|
Long-Term Investments | 27.91 | 27.03 | 142.94 | 67.1 | 17.55 | 54.31 | Upgrade
|
Other Long-Term Assets | 0.26 | 0.26 | 0.26 | 0.26 | 0.32 | 0.14 | Upgrade
|
Total Assets | 493.42 | 452.39 | 610.38 | 643.07 | 416.55 | 435.2 | Upgrade
|
Accounts Payable | 3.59 | 4.7 | 2.78 | 1.74 | 4.22 | 16.24 | Upgrade
|
Accrued Expenses | 37.95 | 30.51 | 21.63 | 12.85 | 15.26 | 11.05 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | - | 1.38 | Upgrade
|
Current Portion of Leases | 1.89 | 1.78 | 1.64 | 1.51 | 0.34 | 0.87 | Upgrade
|
Other Current Liabilities | 0.46 | 0.46 | - | - | - | - | Upgrade
|
Total Current Liabilities | 43.88 | 37.44 | 26.05 | 16.1 | 19.82 | 29.54 | Upgrade
|
Long-Term Debt | 350.56 | 310.81 | 304.41 | 251.09 | - | - | Upgrade
|
Long-Term Leases | 14.61 | 16.04 | 17.81 | 19.45 | - | 0.65 | Upgrade
|
Total Liabilities | 409.05 | 364.29 | 348.28 | 286.64 | 19.82 | 30.19 | Upgrade
|
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
Additional Paid-In Capital | 821.12 | 702.97 | 717.8 | 678.58 | 660.67 | 648.67 | Upgrade
|
Retained Earnings | -737.54 | -614.1 | -450.48 | -321.75 | -263.96 | -244.03 | Upgrade
|
Comprehensive Income & Other | 0.76 | -0.8 | -5.25 | -0.42 | -0 | 0.34 | Upgrade
|
Total Common Equity | 84.37 | 88.1 | 262.1 | 356.43 | 396.73 | 405.01 | Upgrade
|
Shareholders' Equity | 84.37 | 88.1 | 262.1 | 356.43 | 396.73 | 405.01 | Upgrade
|
Total Liabilities & Equity | 493.42 | 452.39 | 610.38 | 643.07 | 416.55 | 435.2 | Upgrade
|
Total Debt | 367.06 | 328.62 | 323.86 | 272.05 | 0.34 | 2.9 | Upgrade
|
Net Cash (Debt) | 63.06 | 62.28 | 117.38 | 276.05 | 393.31 | 371.33 | Upgrade
|
Net Cash Growth | -24.52% | -46.94% | -57.48% | -29.81% | 5.92% | -11.49% | Upgrade
|
Net Cash Per Share | 2.30 | 2.31 | 4.17 | 10.06 | 14.41 | 13.72 | Upgrade
|
Filing Date Shares Outstanding | 30.43 | 26.76 | 27.93 | 27.67 | 27.37 | 27.27 | Upgrade
|
Total Common Shares Outstanding | 30.43 | 26.6 | 28.51 | 27.65 | 27.36 | 27.26 | Upgrade
|
Working Capital | 404.8 | 369.39 | 421.15 | 537.78 | 376.74 | 348.2 | Upgrade
|
Book Value Per Share | 2.77 | 3.31 | 9.19 | 12.89 | 14.50 | 14.86 | Upgrade
|
Tangible Book Value | 84.37 | 88.1 | 262.1 | 356.43 | 396.73 | 405.01 | Upgrade
|
Tangible Book Value Per Share | 2.77 | 3.31 | 9.19 | 12.89 | 14.50 | 14.86 | Upgrade
|
Machinery | 8 | 8.11 | 7.46 | 7 | 6.2 | 5.72 | Upgrade
|
Leasehold Improvements | 0.2 | 0.2 | 0.2 | 0.2 | 0.53 | 0.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.